Skip to main content
. 2026 Feb 9;27:47. doi: 10.1186/s40360-026-01099-y

Table 1.

Participants

Situations of the participants Fasting group Fed group
The enrolled participants n = 30 n = 30
The participants who withdrew or dropped out EMPA-T and EMPA-R: n = 1
EMPA-T: n = 1 EMPA-T: n = 1
EMPA-R: n = 1 EMPA-R: n = 1
The participants who included in the analysis EMPA-R: n = 28 EMPA-R: n = 29
EMPA-T: n = 28 EMPA-T: n = 29

Notes: EMPA-R, a branded empagliflozin was as the reference. EMPA-T, a generic empagliflozin was the test